Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

NCT07019922 ·Status: RECRUITING ·Phase: PHASE3

Stiripentol in Dravet Syndrome

NCT01533506 ·Status: NO_LONGER_AVAILABLE

Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy

NCT00986310 ·Status: COMPLETED ·Phase: NA

Neuroprotection With Phenytoin in Optic Neuritis

NCT01451593 ·Status: COMPLETED ·Phase: PHASE2

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

NCT03370120 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452 ·Status: COMPLETED ·Phase: PHASE3

Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy

NCT02655198 ·Status: UNKNOWN ·Phase: PHASE2

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

NCT04740476 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

NCT04529954 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

NCT01147003 ·Status: COMPLETED ·Phase: PHASE2

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

NCT02926898 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)

NCT04873869 ·Status: TERMINATED ·Phase: PHASE2

Evaluation and Treatment of Patients With Epilepsy

NCT00013845 ·Status: TERMINATED

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

NCT06377930 ·Status: COMPLETED ·Phase: PHASE2

PRX-00023 Therapy in Localization-Related Epilepsy

NCT01281956 ·Status: TERMINATED ·Phase: PHASE2

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

NCT02091375 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures

NCT01921205 ·Status: COMPLETED ·Phase: PHASE3

Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.

NCT01478035 ·Status: TERMINATED ·Phase: PHASE4

Intermittent Fasting in Refractory Epilepsy

NCT02311023 ·Status: TERMINATED ·Phase: PHASE2

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT04999046 ·Status: COMPLETED ·Phase: NA

A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

NCT04940624 ·Status: COMPLETED ·Phase: PHASE3

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

NCT04537832 ·Status: TERMINATED

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451 ·Status: COMPLETED ·Phase: PHASE2

Seizures Post Intracerebral Hemorrhage

NCT01115959 ·Status: COMPLETED ·Phase: PHASE4